U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis
USA - NYSE:USPH - US90337L1089 - Common Stock
91.605 USD
-1.55 (-1.67%)
USPH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. USPH has an average financial health and profitability rating. USPH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year USPH was profitable.
USPH had a positive operating cash flow in the past year.
USPH had positive earnings in each of the past 5 years.
USPH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.93%, USPH is in the better half of the industry, outperforming 63.37% of the companies in the same industry.
The Return On Equity of USPH (6.91%) is better than 65.35% of its industry peers.
The Return On Invested Capital of USPH (5.72%) is better than 60.40% of its industry peers.
USPH had an Average Return On Invested Capital over the past 3 years of 5.78%. This is below the industry average of 9.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROIC | 5.72% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
1.3 Margins
USPH's Profit Margin of 4.74% is fine compared to the rest of the industry. USPH outperforms 76.24% of its industry peers.
In the last couple of years the Profit Margin of USPH has declined.
With an excellent Operating Margin value of 11.00%, USPH belongs to the best of the industry, outperforming 80.20% of the companies in the same industry.
USPH's Operating Margin has declined in the last couple of years.
USPH has a Gross Margin of 18.96%. This is in the lower half of the industry: USPH underperforms 61.39% of its industry peers.
USPH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% |
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
2. Health
2.1 Basic Checks
USPH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
USPH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, USPH has more shares outstanding
Compared to 1 year ago, USPH has an improved debt to assets ratio.
2.2 Solvency
USPH has an Altman-Z score of 2.40. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of USPH (2.40) is comparable to the rest of the industry.
The Debt to FCF ratio of USPH is 2.63, which is a good value as it means it would take USPH, 2.63 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.63, USPH belongs to the best of the industry, outperforming 81.19% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that USPH is not too dependend on debt financing.
The Debt to Equity ratio of USPH (0.30) is better than 65.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.63
WACC9.02%
2.3 Liquidity
USPH has a Current Ratio of 1.18. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.18, USPH is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
A Quick Ratio of 1.18 indicates that USPH should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.18, USPH is in line with its industry, outperforming 43.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.35% over the past year.
Measured over the past years, USPH shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.76% on average per year.
Looking at the last year, USPH shows a quite strong growth in Revenue. The Revenue has grown by 16.24% in the last year.
The Revenue has been growing slightly by 6.85% on average over the past years.
EPS 1Y (TTM)7.35%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.96%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.04%
3.2 Future
USPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.98% yearly.
The Revenue is expected to grow by 9.97% on average over the next years. This is quite good.
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 34.83, which means the current valuation is very expensive for USPH.
Compared to the rest of the industry, the Price/Earnings ratio of USPH is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.89, USPH is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 29.37, the valuation of USPH can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as USPH.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, USPH is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.83 | ||
| Fwd PE | 29.37 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as USPH.
Based on the Price/Free Cash Flow ratio, USPH is valued a bit cheaper than 61.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.87 | ||
| EV/EBITDA | 15.08 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.71
PEG (5Y)N/A
EPS Next 2Y9.96%
EPS Next 3Y9.98%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.97%, USPH has a reasonable but not impressive dividend return.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.42. USPH pays more dividend than 90.10% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, USPH has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.97% |
5.2 History
On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has been paying a dividend for at least 10 years, so it has a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
USPH pays out 77.94% of its income as dividend. This is not a sustainable payout ratio.
The dividend of USPH is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP77.94%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
NYSE:USPH (10/27/2025, 1:39:41 PM)
91.605
-1.55 (-1.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners105.82%
Inst Owner Change0.09%
Ins Owners1.84%
Ins Owner Change0.17%
Market Cap1.39B
Revenue(TTM)729.61M
Net Income(TTM)34.59M
Analysts84.62
Price Target108.32 (18.25%)
Short Float %5.35%
Short Ratio5.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.97% |
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP77.94%
Div Incr Years4
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.25%
Min EPS beat(2)9.44%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.96%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.31%
EPS beat(12)5
Avg EPS beat(12)-0.32%
EPS beat(16)8
Avg EPS beat(16)0%
Revenue beat(2)2
Avg Revenue beat(2)1.85%
Min Revenue beat(2)1.65%
Max Revenue beat(2)2.04%
Revenue beat(4)4
Avg Revenue beat(4)1.28%
Min Revenue beat(4)0.22%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.67%
Revenue beat(12)7
Avg Revenue beat(12)0.35%
Revenue beat(16)8
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)0.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.55%
EPS NY rev (1m)0%
EPS NY rev (3m)8.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.83 | ||
| Fwd PE | 29.37 | ||
| P/S | 1.91 | ||
| P/FCF | 22.87 | ||
| P/OCF | 19.42 | ||
| P/B | 2.78 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.08 |
EPS(TTM)2.63
EY2.87%
EPS(NY)3.12
Fwd EY3.41%
FCF(TTM)4
FCFY4.37%
OCF(TTM)4.72
OCFY5.15%
SpS48
BVpS32.94
TBVpS-23.19
PEG (NY)3.71
PEG (5Y)N/A
Graham Number44.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.93% | ||
| ROE | 6.91% | ||
| ROCE | 7.57% | ||
| ROIC | 5.72% | ||
| ROICexc | 5.91% | ||
| ROICexgc | 34.97% | ||
| OM | 11% | ||
| PM (TTM) | 4.74% | ||
| GM | 18.96% | ||
| FCFM | 8.34% |
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.63 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 49.29% | ||
| Cap/Sales | 1.49% | ||
| Interest Coverage | 9.81 | ||
| Cash Conversion | 70.13% | ||
| Profit Quality | 176.01% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 2.4 |
F-Score6
WACC9.02%
ROIC/WACC0.63
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)7.35%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%10.96%
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue 1Y (TTM)16.24%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%18.04%
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
EBIT growth 1Y19.82%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.12%
EBIT Next 3Y18.72%
EBIT Next 5YN/A
FCF growth 1Y-1.2%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y2.73%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%
U.S. PHYSICAL THERAPY INC / USPH FAQ
What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?
ChartMill assigns a fundamental rating of 5 / 10 to USPH.
Can you provide the valuation status for U.S. PHYSICAL THERAPY INC?
ChartMill assigns a valuation rating of 2 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Overvalued.
What is the profitability of USPH stock?
U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for USPH stock?
The Earnings per Share (EPS) of U.S. PHYSICAL THERAPY INC (USPH) is expected to grow by 9.38% in the next year.
Can you provide the dividend sustainability for USPH stock?
The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 77.94%.